A novel protein domain in an ancestral splicing factor drove the evolution of neural microexons.


Journal

Nature ecology & evolution
ISSN: 2397-334X
Titre abrégé: Nat Ecol Evol
Pays: England
ID NLM: 101698577

Informations de publication

Date de publication:
04 2019
Historique:
received: 26 07 2018
accepted: 16 01 2019
pubmed: 6 3 2019
medline: 14 6 2019
entrez: 6 3 2019
Statut: ppublish

Résumé

The mechanisms by which entire programmes of gene regulation emerged during evolution are poorly understood. Neuronal microexons represent the most conserved class of alternative splicing in vertebrates, and are critical for proper brain development and function. Here, we discover neural microexon programmes in non-vertebrate species and trace their origin to bilaterian ancestors through the emergence of a previously uncharacterized 'enhancer of microexons' (eMIC) protein domain. The eMIC domain originated as an alternative, neural-enriched splice isoform of the pan-eukaryotic Srrm2/SRm300 splicing factor gene, and subsequently became fixed in the vertebrate and neuronal-specific splicing regulator Srrm4/nSR100 and its paralogue Srrm3. Remarkably, the eMIC domain is necessary and sufficient for microexon splicing, and functions by interacting with the earliest components required for exon recognition. The emergence of a novel domain with restricted expression in the nervous system thus resulted in the evolution of splicing programmes that qualitatively expanded the neuronal molecular complexity in bilaterians.

Identifiants

pubmed: 30833759
doi: 10.1038/s41559-019-0813-6
pii: 10.1038/s41559-019-0813-6
doi:

Substances chimiques

RNA Splicing Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-701

Commentaires et corrections

Type : CommentIn

Auteurs

Antonio Torres-Méndez (A)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.

Sophie Bonnal (S)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.

Yamile Marquez (Y)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.

Jonathan Roth (J)

Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Marta Iglesias (M)

Sars Centre for Marine Molecular Biology, University of Bergen, Bergen, Norway.

Jon Permanyer (J)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.

Isabel Almudí (I)

Centro Andaluz de Biología del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andalucía, Seville, Spain.

Dave O'Hanlon (D)

Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.

Tanit Guitart (T)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.

Matthias Soller (M)

School of Biosciences, College of Life and Environmental Sciences, University of Birmingham, Birmingham, UK.

Anne-Claude Gingras (AC)

Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Fátima Gebauer (F)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.

Fabian Rentzsch (F)

Sars Centre for Marine Molecular Biology, University of Bergen, Bergen, Norway.
Department of Biological Sciences, University of Bergen, Bergen, Norway.

Benjamin J Blencowe (BJ)

Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.

Juan Valcárcel (J)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Universitat Pompeu Fabra, Barcelona, Spain.
ICREA, Barcelona, Spain.

Manuel Irimia (M)

Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. mirimia@gmail.com.
Universitat Pompeu Fabra, Barcelona, Spain. mirimia@gmail.com.
ICREA, Barcelona, Spain. mirimia@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH